3D Bioprinting and Development of Glioblastoma Treatment Models: a Systematic Review
Authors:
- George AgiotisGAGeorge Agiotis
- Konstantinos TerlemesKTKonstantinos Terlemes
- Mikaella ShakalliMSMikaella Shakalli
- Vasileios K. KavouridisVKVasileios K. Kavouridis
- Georgios FotakopoulosGFGeorgios Fotakopoulos
- Evangelos KogiasEvangelos Kogias
- 9 July 2026
- journal article
- review article
- Published by Elsevier in Bioprinting
- Vol. 58
Abstract
No abstract availableThis publication has 59 references indexed in Scilit:
- Evolution of Preclinical Models for Glioblastoma Modelling and Drug ScreeningCurrent Oncology Reports, 2025
- Rapid Biofabrication of an Advanced Microphysiological System Mimicking Phenotypical Heterogeneity and Drug Resistance in GlioblastomaAdvanced Healthcare Materials, 2024
- Development of a biocompatible 3D hydrogel scaffold using continuous liquid interface production for the delivery of cell therapies to treat recurrent glioblastomaBioengineering & Translational Medicine, 2024
- Radiotherapy Resistance of 3D Bioprinted Glioma via ITGA2/p‐AKT Signaling PathwayAdvanced Healthcare Materials, 2024
- Spatiotemporal T cell dynamics in a 3D bioprinted immunotherapy modelBioprinting, 2022
- Rapid 3D Bioprinting of Glioblastoma Model Mimicking Native Biophysical HeterogeneitySmall, 2021
- A novel 3D in vitro model of glioblastoma reveals resistance to temozolomide which was potentiated by hypoxiaJournal of Neuro-Oncology, 2019
- 3D bioprinted glioma cell‐laden scaffolds enriching glioma stem cells via epithelial–mesenchymal transitionJournal of Biomedical Materials Research Part A, 2018
- Radiotherapy and the Tumor Microenvironment: Mutual Influence and Clinical Implications2013
- First-line treatment of malignant glioma with carmustine implants followed by concomitant radiochemotherapy: a multicenter experienceNeurosurgical Review, 2010